PAPER Takano M, Tashiro E, Kitamura A, Maita H, Iguchi-Ariga SM, Kinjo M, Ariga H
SEARCH RESULTS
330059 RESULTS
PAPER Nuber S, Tadros D, Fields J, Overk CR, Ettle B, Kosberg K, Mante M, Rockenstein E, Trejo M, Masliah E
Environmental neurotoxic challenge of conditional alpha-synuclein transgenic mice predicts a dopaminergic olfactory-striatal interplay in early PD.
Acta Neuropathol. 2014 Apr;127(4):477-94. Epub 2014 Feb 8 PubMed: 24509835PAPER Mondello S, Constantinescu R, Zetterberg H, Andreasson U, Holmberg B, Jeromin A
CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders.
Parkinsonism Relat Disord. 2014 Apr;20(4):382-7. Epub 2014 Jan 22 PubMed: 24507721PAPER Gurnev PA, Yap TL, Pfefferkorn CM, Rostovtseva TK, Berezhkovskii AM, Lee JC, Parsegian VA, Bezrukov SM
Alpha-synuclein lipid-dependent membrane binding and translocation through the α-hemolysin channel.
Biophys J. 2014 Feb 4;106(3):556-65. PubMed: 24507596PAPER Low PA, Robertson D, Gilman S, Kaufmann H, Singer W, Biaggioni I, Freeman R, Perlman S, Hauser RA, Cheshire W, Lessig S, Vernino S, Mandrekar J, Dupont WD, Chelimsky T, Galpern WR
Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial.
Lancet Neurol. 2014 Mar;13(3):268-75. Epub 2014 Feb 5 PubMed: 24507091PAPER Feldman EL, Boulis NM, Hur J, Johe K, Rutkove SB, Federici T, Polak M, Bordeau J, Sakowski SA, Glass JD
Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes.
Ann Neurol. 2014 Mar;75(3):363-73. Epub 2014 Mar 7 PubMed: 24510776PAPER Majmudar S, Wu J, Paganoni S
Rehabilitation in amyotrophic lateral sclerosis: why it matters.
Muscle Nerve. 2014 Jul;50(1):4-13. Epub 2014 May 17 PubMed: 24510737PAPER Valavanis A, Schwarz U, Baumann CR, Weller M, Linnebank M
Amyotrophic lateral sclerosis after embolization of cerebral arterioveneous malformations.
J Neurol. 2014 Apr;261(4):732-7. Epub 2014 Feb 8 PubMed: 24509642PAPER Qiu H, Lee S, Shang Y, Wang WY, Au KF, Kamiya S, Barmada SJ, Finkbeiner S, Lui H, Carlton CE, Tang AA, Oldham MC, Wang H, Shorter J, Filiano AJ, Roberson ED, Tourtellotte WG, Chen B, Tsai LH, Huang EJ
ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects.
J Clin Invest. 2014 Mar 3;124(3):981-99. Epub 2014 Feb 10 PubMed: 24509083PAPER Gascon E, Gao FB
The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders.
J Neurogenet. 2014 Mar-Jun;28(1-2):30-40. Epub 2014 Feb 10 PubMed: 24506814PAPER
Alzheimer's Association update.
Alzheimers Dement. 2014 Jan;10(1):132-3. PubMed: 24511628PAPER Robin NC, Agoston Z, Biechele TL, James RG, Berndt JD, Moon RT
Simvastatin Promotes Adult Hippocampal Neurogenesis by Enhancing Wnt/β-Catenin Signaling.
Stem Cell Reports. 2014 Jan 14;2(1):9-17. Epub 2013 Dec 26 PubMed: 24511465PAPER Canudas J, Insua D, Sarasa L, González-Martínez A, Suárez ML, Santamarina G, Pesini P, Sarasa M
Neprilysin is poorly expressed in the prefrontal cortex of aged dogs with cognitive dysfunction syndrome.
Int J Alzheimers Dis. 2014;2014:483281. Epub 2014 Jan 6 PubMed: 24511411PAPER Foster DJ, Choi DL, Conn PJ, Rook JM
Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer's disease and schizophrenia.
Neuropsychiatr Dis Treat. 2014;10:183-91. Epub 2014 Jan 28 PubMed: 24511233PAPER Ihara M, Taguchi A, Maki T, Washida K, Tomimoto H
A mouse model of chronic cerebral hypoperfusion characterizing features of vascular cognitive impairment.
Methods Mol Biol. 2014;1135:95-102. PubMed: 24510857Current Filters
No filters selected